Latest Competition News

Bluechiip Limited remains in ASX suspension as it finalises its 2024 audited accounts, while its ongoing Strategic Review and BioLife deal set the stage for a pivotal 2025 focused on revenue growth and cash-flow break-even.

Midas Minerals reports steady progress in its Western Australian gold and base metals projects alongside a $1.6 million capital raising, positioning the company for upcoming drill target definitions.

Pinnacle Minerals Ltd reports a strategic shift towards cost reduction and partnership development across its lithium, uranium, and rare earth projects, positioning itself for future growth.

MFF Capital Investments Limited has reported a striking net profit after tax of $381.5 million for the half year ended December 31, 2024, more than doubling last year’s result. The company also announced an increased fully franked interim dividend of 8 cents per share, underscoring its robust financial position and growth trajectory.

Cycliq Group Ltd reports a robust Q2 FY2025 with a 15% rise in cash receipts to $1.92 million and strategic leadership appointments aimed at accelerating growth.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

IXUP Limited reports strong sales momentum driven by its largest-ever contract with iGaming Ontario, alongside strategic cost reductions and a clear path to positive cash flow by late 2025.

SportsHero Limited has inked a five-year partnership with Indonesia's Indosat Ooredoo Hutchison to market its Family Game Room product, alongside securing a $1 million debt facility to support its expansion plans.

Evion Group has initiated shipments from its expandable graphite joint venture in India, securing initial sales of A$2 million, while making significant progress on mining licenses and community support for its Maniry Graphite Project in Madagascar.

Lake Resources NL reported a robust cash position of AUD 22.56 million for Q4 2024, bolstered by a $13.6 million sale of non-core assets and steady progress on the Kachi lithium project’s environmental and engineering milestones.

InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.